- Home
- DPRO vs PMVP Comparison
DPRO vs PMVP Comparison
Compare DPRO & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DPRO
- PMVP
- Stock Information
- Founded
- DPRO 1998
- PMVP 2013
- Country
- DPRO Canada
- PMVP United States
- Employees
- DPRO N/A
- PMVP N/A
- Industry
- DPRO Aerospace
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- DPRO Industrials
- PMVP Health Care
- Exchange
- DPRO Nasdaq
- PMVP Nasdaq
- Market Cap
- DPRO 81.2M
- PMVP 77.4M
- IPO Year
- DPRO N/A
- PMVP 2020
- Fundamental
- Price
- DPRO $5.17
- PMVP $1.25
- Analyst Decision
- DPRO Strong Buy
- PMVP Strong Buy
- Analyst Count
- DPRO 2
- PMVP 1
- Target Price
- DPRO $6.50
- PMVP $5.00
- AVG Volume (30 Days)
- DPRO 1.4M
- PMVP 2.7M
- Earning Date
- DPRO 11-13-2025
- PMVP 11-06-2025
- Dividend Yield
- DPRO N/A
- PMVP N/A
- EPS Growth
- DPRO N/A
- PMVP N/A
- EPS
- DPRO N/A
- PMVP N/A
- Revenue
- DPRO $5,250,872.00
- PMVP N/A
- Revenue This Year
- DPRO $41.59
- PMVP N/A
- Revenue Next Year
- DPRO $132.11
- PMVP N/A
- P/E Ratio
- DPRO N/A
- PMVP N/A
- Revenue Growth
- DPRO 17.08
- PMVP N/A
- 52 Week Low
- DPRO $1.63
- PMVP $0.81
- 52 Week High
- DPRO $7.31
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- DPRO 57.24
- PMVP 43.13
- Support Level
- DPRO $4.99
- PMVP $1.12
- Resistance Level
- DPRO $5.40
- PMVP $1.35
- Average True Range (ATR)
- DPRO 0.32
- PMVP 0.16
- MACD
- DPRO 0.06
- PMVP -0.03
- Stochastic Oscillator
- DPRO 79.09
- PMVP 17.25
About DPRO Draganfly Inc.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.